Evoke Pharma (EVOK) Tops Q2 EPS by 17c

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.56), $0.17 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $1.13 million versus the consensus estimate of $1.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform